Stay updated on Foralumab Safety in NASH and T2DM Clinical Trial
Sign up to get notified when there's something new on the Foralumab Safety in NASH and T2DM Clinical Trial page.

Latest updates to the Foralumab Safety in NASH and T2DM Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedA new revision v3.4.2 is added to the study history, and the previous revision v3.4.1 is removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check19 days agoChange DetectedThe revision history now reflects the addition of v3.4.1 and the removal of v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check33 days agoChange DetectedUI text changes on the record history page include a glossary toggle (Show glossary / Hide glossary) and added color-coding guidance for changes (green/red highlights). Footer revision label updated to v3.4.0 and 'No FEAR Act Data' text appears in the additions, replacing the previous v3.3.4; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check40 days agoChange DetectedThe record history shows a new revision entry (v3.3.4) and the removal of v3.3.3, reflecting metadata updates to the record. These changes do not modify the visible study details on the page.SummaryDifference0.1%

- Check69 days agoChange DetectedThe history now includes Revision: v3.3.3; the HHS Vulnerability Disclosure and Revision: v3.3.2 entries were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check90 days agoChange DetectedRevision history now includes revision v3.3.2 and no longer shows revision v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Foralumab Safety in NASH and T2DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Foralumab Safety in NASH and T2DM Clinical Trial page.